GW pharmaceuticals shorts take Gamble ahead of conference

GW Pharmaceuticals saw its short interest increase by 228% in just two weeks at the end of April. The stock then proceeded to drop 4% at the beginning of May even though the company reported its earnings on May 7. GW Pharmaceuticals will also be pre